Icares Medicus Inc (6612) — Cash Flow Reinvestment Rate
Icares Medicus Inc (6612) has a Cash Flow Reinvestment Rate of 0.40x as of June 2025, reinvesting NT$44.14 Million (capex NT$20.18 Million plus investments NT$-23.96 Million) from operating cash flow of NT$111.22 Million. Check Icares Medicus Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Icares Medicus Inc Cash Flow Reinvestment Rate (2017–2022)
Historical reinvestment intensity for Icares Medicus Inc across 6 annual periods. Explore 6612 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Icares Medicus Inc (2017–2022)
Year-by-year capital reinvestment analysis for Icares Medicus Inc. For live market cap and broader valuation context, see 6612 market cap.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.56x | NT$201.10 Million | NT$128.92 Million | NT$34.03 Million | ▼ -65.3% |
| 2021 | 4.50x | NT$173.55 Million | NT$38.57 Million | NT$6.48 Million | ▲ +348.7% |
| 2020 | 1.00x | NT$71.57 Million | NT$71.37 Million | NT$11.20 Million | ▼ -42.1% |
| 2019 | 1.73x | NT$153.79 Million | NT$88.78 Million | NT$93.41 Million | ▲ +1097.3% |
| 2018 | 0.14x | NT$9.15 Million | NT$63.22 Million | NT$6.08 Million | ▼ -42.9% |
| 2017 | 0.25x | NT$11.52 Million | NT$45.47 Million | NT$8.44 Million | — |